SMS Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2025 ,inter alia, to consider and approve Audited Financial Results ....
SMSPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
SMS Pharmaceuticals has informed the exchanges about a Board of Directors meeting scheduled for Friday, 30th May 2025 at its registered office in Hyderabad. The Board will consider and approve the Audited Financial Results (both Standalone and Consolidated) for Q4 and the financial year ended 31st March 2025. It will also consider and recommend a dividend, if any, for FY2024-25, along with any other business items. The trading window for designated persons and directors has been closed from 1st April 2025 and will reopen on 2nd June 2025 in line with insider trading rules.
This is a routine intimation of an upcoming board meeting. Investors should watch for the actual audited results and dividend announcement on or after 30th May 2025, which could impact the stock price depending on earnings performance and dividend declared.